Genome editing therapies end research drought for sickle cell - STAT

Genome editing therapies end research drought for sickle cell - STAT

STAT Plus: Deluge of genome editing therapies end research drought for sickle cell disease

By SHARON BEGLEY

UCL MEDICAL SCHOOL/WELLCOME IMAGES

Beam Therapeutics has gotten an experimental sickle cell therapy to produce high levels of healthy hemoglobin in mice, paving the way for human trials.

READ MORE